Literature DB >> 2201641

A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.

S B Calderwood1, D W Acheson, M B Goldberg, S A Boyko, A Donohue-Rolfe.   

Abstract

We have constructed a plasmid expression vector (pSBC32) that encodes the B subunit of Shiga toxin/Shiga-like toxin I under control of the inducible trc promoter. The encoded B subunit is transported to the periplasmic space, allowing single-step purification of milligram amounts of this protein from periplasmic extracts by using receptor analog affinity chromatography. The purified B subunit interacts normally with both polyclonal antiserum to Shiga toxin and a monoclonal antibody specific for B subunit. B subunit purified in this system is pentameric (as in native holotoxin) and biologically active in blocking binding of Shiga holotoxin to HeLa cells. This expression system may allow rapid purification of sufficient amounts of Shiga toxin B subunit to attempt crystallization or to study its efficacy as a vaccine, either by itself or coupled to an appropriate polysaccharide antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201641      PMCID: PMC313598          DOI: 10.1128/iai.58.9.2977-2982.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.

Authors:  J E Samuel; L P Perera; S Ward; A D O'Brien; V Ginsburg; H C Krivan
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Restriction in vivo. III. General effects of glucosylation and restriction on phage T4 gene expression and replication.

Authors:  K Dharmalingam; E B Goldberg
Journal:  Virology       Date:  1979-07-30       Impact factor: 3.616

3.  Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.

Authors:  A O O'Brien; T A Lively; M E Chen; S W Rothman; S B Formal
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

4.  Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin.

Authors:  K Eiklid; S Olsnes
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

5.  The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I.

Authors:  G T Keusch; G F Grady; L J Mata; J McIver
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

6.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

7.  Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck; M R Thompson; S B Formal
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

8.  Subunit structure of Shigella cytotoxin.

Authors:  S Olsnes; R Reisbig; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

9.  The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.

Authors:  R Reisbig; S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

10.  Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.

Authors:  A Donohue-Rolfe; G T Keusch; C Edson; D Thorley-Lawson; M Jacewicz
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  11 in total

1.  Polyclonal antibodies to glutathione S-transferase--verotoxin subunit a fusion proteins neutralize verotoxins.

Authors:  P H M Leung; J S M Peiris; W W S Ng; W C Yam
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application.

Authors:  S Miyashita; Y Matsuura; D Miyamoto; Y Suzuki; Y Imai
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

3.  Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.

Authors:  P R Austin; P E Jablonski; G A Bohach; A K Dunker; C J Hovde
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains.

Authors:  J R Butterton; E T Ryan; D W Acheson; S B Calderwood
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases.

Authors:  G H Foster; C S Armstrong; R Sakiri; V L Tesh
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells.

Authors:  Paola Marcato; George Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Expression and purification of Shiga-like toxin II B subunits.

Authors:  D W Acheson; S A De Breucker; M Jacewicz; L L Lincicome; A Donohue-Rolfe; A V Kane; G T Keusch
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.

Authors:  D W Acheson; S B Calderwood; S A Boyko; L L Lincicome; A V Kane; A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

9.  Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis.

Authors:  C Jemal; J E Haddad; D Begum; M P Jackson
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

10.  Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization.

Authors:  Yasuyuki Imai; Rio Nagai; Yousuke Ono; Tomoyuki Ishikawa; Hiroki Nakagami; Takashi Tanikawa; Kohta Kurohane
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.